BioCentury
ARTICLE | Company News

Shearwater to PEGylate Regeneron's Axokine

December 4, 2000 8:00 AM UTC

Shearwater (Huntsville, Ala.) will use its PEGylation technology to develop a PEGylated form of REGN's Axokine second generation ciliary neurotrophic factor ( CNTF) to treat obesity. Shearwater will r...